Glossary of terms and useful resources related to poliovirus containment

The following definitions and resources are provided to assist the reader in following global, regional and national developments related to poliovirus containment. Technical documents are also provided to support poliovirus containment efforts at national level.

  • AFP      Acute flaccid paralysis
  • BRM     biorisk management
  • CCS     Poliovirus Containment Certification Scheme
  • CEN     European Committee for Standardization
  • EPLN   European Polio Laboratory Network
  • GAPIII  WHO global action plan to minimize poliovirus facility-associated risk after type-specific
  • GCC    Global Commission for the Certification of Poliomyelitis Eradication
  • GPEI    Global Polio Eradication Initiative
  • ICC       interim containment certification
  • IPV       inactivated polio vaccine
  • LDMS   Laboratory Database Monitoring System
  • NAC     National Authority for Containment
  • NPCC   National Poliovirus Containment Coordinator
  • OPV      oral polio vaccine
    • bOPV:    bivalent oral polio vaccine containing type 1 and type 3
    • mOPV:   monovalent oral polio vaccine containing one type only
    • mOPV2: monovalent oral polio vaccine type 2
    • tOPV:      trivalent oral polio vaccine containing type 1, type 2 and type 3
  • PEF    poliovirus essential facility
  • PPE    personal protective equipment
  • PV      poliovirus
  • SAGE Strategic Advisory Group of Experts on immunization
  • VAPP  vaccine-associated paralytic poliomyelitis
  • VDPV vaccine-derived poliovirus
  • WHA  World Health Assembly
  • WPV  wild type polioviruses
  • WHA  World Health Assembly
Key points: What you need to know about the containment of polioviruses

Polio Eradication and Endgame Strategic Plan 2013–2018

Global Polio Eradication Initiative – weekly updates

GAP III: WHO global action plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of OPV use (2014)

In English (PDF, 2.5 MB)

GAP III: in French

(PDF, 2.5 MB)

Meeting of the WHO Strategic Advisory Group of Experts on Immunization (SAGE), April 2016

Review of OPV switch implementation

Meeting of the WHO Strategic Advisory Group of Experts on Immunization (SAGE), October 2015

Confirmation of April 2016 as the date for the global OPV switch

Declaration of global wild poliovirus type 2 eradication, September 2015

Plans for containment of poliovirus following type-specific polio eradication worldwide

Weekly Epidemiological Record, August 2015

WHO Guidelines for containment of poliovirus following type-specific polio eradication—worldwide, 2015

Morbidity and Mortality Weekly Report, August 2015

World Health Assembly resolution WHA68.3 on poliomyelitis, 26 May 2015

Meeting of the WHO Strategic Advisory Group of Experts (SAGE), October 2014

Review of readiness criteria for type 2 oral poliovirus vaccine (OPV) withdrawal globally

Regional Polio Lab Network: Online Laboratory Data Management System (LDMS)

Belgian Biosafety Server

Science-based information related to biosafety for professionals in the medical, veterinary, agronomical and biotechnological sectors

Danish Center for Biosecurity and biopreparedness

Biorisk management. Laboratory biosecurity guidance (2006)

Responsible life sciences research for global health security. A guidance document (2010)